European Pharmaceutical Review

DECEMBER 19, 2022

1 The resulting weakness can lead to twitching, cramps, pain, and joint and movement problems. 1 Types of NMD include muscular dystrophies, inflammatory myopathies and motor neurone diseases, such as spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS) among others. Journal of Neuromuscular Diseases.

Patients 86

Patients Recruitment Pharmaceutical Leads 86

Pharmaceutical Technology

AUGUST 11, 2022

CO 2 e kg) (Figure 1). One dose from a DPI leads to only 4% of the emissions of a dose from a pMDI (Figure 1). A study published in the British Medical Journal (BMJ) monitored, over the course of a year, the effect of transitioning patients from their preexisting asthma treatment plan to DPIs.

Leads 64

Leads Patients Pharma Sales 64

pharmaphorum

JANUARY 19, 2023

It was a unique event, at which leaders from across the pharmaceutical pipeline addressed the needs of the industry, shared their own insights, and tackled debates on the crucial topics that influence the future of patient outcomes. Where we are today is probably the least resilient system in Europe.”

Pharma 74

Pharma Competition Healthcare Healthcare 74

European Pharmaceutical Review

DECEMBER 15, 2022

1–3 This broad class of serotonergic agents, such as psilocybin, can produce changes in sensory perception, mood and thought processes. As late-stage development continues, COMPASS Pathways is running a rigorous, Phase III clinical development programme of its psilocybin therapy for TRD across Europe and North America.

Food and Drug Administration 69

Food and Drug Administration Healthcare Healthcare Food 69

Evolve Your Success

FEBRUARY 7, 2023

What led me to that was a long career as a med device rep in the cardiovascular world launching products for big companies like several startup companies, transformational cardiovascular technology, building sales teams and creating distributors internationally. We went out and sold $1 billion in that first year. It’s sales 101.

Medical 52

Medical Sales Medical sales Doctors 52

European Pharmaceutical Review

DECEMBER 27, 2023

1 Following in vitro production from T cells collected from a patient’s leukapheresis procedure, the CAR T cells are infused back into the patient’s blood, where they proliferate and expand. Journal of Hematology & Oncology. 2019;12(1). New England Journal of Medicine. 2022;140(Supplement 1):4633–5.

Manufacturing 90

Manufacturing Food and Drug Administration Patients Pharma 90